11C-labeled and18F-labeled PET ligands for subtype-specific imaging of histamine receptors in the brain

作者: Uta Funke , Danielle J. Vugts , Bieneke Janssen , Arnold Spaans , Perry S. Kruijer

DOI: 10.1002/JLCR.3038

关键词:

摘要: The signaling molecule histamine plays a key role in the mediation of immune reactions, gastric secretion, and sensory system. In addition, it has an important function as neurotransmitter central nervous system, acting pituitary hormone wakefulness, motor cognitive functions, well itch nociception. This raised interest histaminergic system for treatment diagnosis various pathologies such allergy, sleeping eating disorders, neurodegeneration, neuroinflammation, mood pruritus. In past 20 years, several ligands targeting four different receptor subtypes have been explored potential radiotracers positron emission tomography (PET). contribution provides overview developments subtype-selective carbon-11-labeled fluorine-18-labeled compounds imaging brain. Using specific radioligands, H1R expression human brain could be examined diseases schizophrenia, depression, anorexia nervosa. sedative effects antihistamines investigated terms occupancy. H3R is special because its regulatory release other neurotransmitters, initial PET studies humans reported. H4R youngest member family involved neuroinflammation pathways. To date, two H4R-specific 11C-labeled synthesized, vivo early stage.

参考文章(103)
Gerold Bongers, Iwan de Esch, Rob Leurs, Molecular pharmacology of the four histamine receptors. Advances in Experimental Medicine and Biology. ,vol. 709, pp. 11- 19 ,(2010) , 10.1007/978-1-4419-8056-4_2
Fuqu Yu, Pascal Bonaventure, Robin L. Thurmond, The future antihistamines: histamine H3 and H4 receptor ligands. Advances in Experimental Medicine and Biology. ,vol. 709, pp. 125- 140 ,(2010) , 10.1007/978-1-4419-8056-4_12
Masaaki Tagawa, Michiko Kano, Nobuyuki Okamura, Makoto Higuchi, Michiaki Matsuda, Yasuyuki Mizuki, Hiroyuki Arai, Ren Iwata, Toshihiko Fujii, Sadao Komemushi, Tatsuo Ido, Masatoshi Itoh, Hidetada Sasaki, Takehiko Watanabe, Kazuhiko Yanai, Neuroimaging of histamine H1‐receptor occupancy in human brain by positron emission tomography (PET): A comparative study of ebastine, a second‐generation antihistamine, and (+)‐chlorpheniramine, a classical antihistamine British Journal of Clinical Pharmacology. ,vol. 52, pp. 501- 509 ,(2001) , 10.1046/J.1365-2125.2001.01471.X
Ekaterini Tiligada, Konstantinos Kyriakidis, Paul L. Chazot, M. Beatrice Passani, Histamine pharmacology and new CNS drug targets. CNS Neuroscience & Therapeutics. ,vol. 17, pp. 620- 628 ,(2011) , 10.1111/J.1755-5949.2010.00212.X
Anayansi Molina-Hernández, Néstor Fabián Díaz, José-Antonio Arias-Montaño, Histamine in brain development. Journal of Neurochemistry. ,vol. 122, pp. 872- 882 ,(2012) , 10.1111/J.1471-4159.2012.07863.X
Roxana del Rio, Rajkumar Noubade, Naresha Saligrama, Emma H. Wall, Dimitry N. Krementsov, Matthew E. Poynter, James F. Zachary, Robin L. Thurmond, Cory Teuscher, Histamine H4 Receptor Optimizes T Regulatory Cell Frequency and Facilitates Anti-Inflammatory Responses within the Central Nervous System Journal of Immunology. ,vol. 188, pp. 541- 547 ,(2012) , 10.4049/JIMMUNOL.1101498
WM Connelly, FC Shenton, N Lethbridge, R Leurs, HJ Waldvogel, RLM Faull, G Lees, PL Chazot, The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS. British Journal of Pharmacology. ,vol. 157, pp. 55- 63 ,(2009) , 10.1111/J.1476-5381.2009.00227.X
Saara Nuutinen, Pertti Panula, Histamine in neurotransmission and brain diseases. Advances in Experimental Medicine and Biology. ,vol. 709, pp. 95- 107 ,(2010) , 10.1007/978-1-4419-8056-4_10
S. Ashworth, E. A. Rabiner, R. N. Gunn, C. Plisson, A. A. Wilson, R. A. Comley, R. Y. K. Lai, A. D. Gee, M. Laruelle, V. J. Cunningham, Evaluation of 11C-GSK189254 as a Novel Radioligand for the H3 Receptor in Humans Using PET The Journal of Nuclear Medicine. ,vol. 51, pp. 1021- 1029 ,(2010) , 10.2967/JNUMED.109.071753